Distress and quality of life in primary high-grade brain tumor patients.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 19421789)

Published in Support Care Cancer on May 07, 2009

Authors

Elizabeth A Kvale1, Rashmi Murthy, Richard Taylor, Jeannette Y Lee, L B Nabors

Author Affiliations

1: Birmingham VA Medical Center, University of Alabama at Birmingham, Birmingham, AL, USA. ekvale@aging.uab.edu

Articles citing this

Review on quality of life issues in patients with primary brain tumors. Oncologist (2010) 1.24

Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol (2012) 1.01

Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma. Neuro Oncol (2011) 1.01

The frequency, longitudinal course, clinical associations, and causes of emotional distress during primary treatment of cerebral glioma. Neuro Oncol (2013) 0.98

Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase. Support Care Cancer (2010) 0.84

Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients. Wien Klin Wochenschr (2012) 0.82

Cognitive strategies and quality of life of patients with high-grade glioma. Support Care Cancer (2015) 0.82

Acute stress in patients with brain cancer during primary care. Support Care Cancer (2011) 0.81

Attitudes and preferences toward monitoring symptoms, distress, and quality of life in glioma patients and their informal caregivers. Support Care Cancer (2016) 0.81

Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review. Support Care Cancer (2014) 0.78

Screening for Psychological Distress in Adult Primary Brain Tumor Patients and Caregivers: Considerations for Cancer Care Coordination. Front Oncol (2015) 0.76

Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting. J Neurooncol (2016) 0.76

Breathlessness with pulmonary metastases: a multimodal approach. J Adv Pract Oncol (2013) 0.75

Experiencing brain cancer: what physicians should know about patients. Ecancermedicalscience (2015) 0.75

Articles cited by this

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol (2002) 4.50

Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol (2002) 3.99

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer (1993) 3.69

Screening for psychologic distress in ambulatory cancer patients. Cancer (2005) 2.74

Oncologists' recognition of depression in their patients with cancer. J Clin Oncol (1998) 2.69

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer (1995) 2.55

Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage (2007) 1.83

Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol (2006) 1.50

Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol (2002) 1.50

Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns (2008) 1.28

A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery (2005) 1.23

Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry (2005) 1.17

Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma. J Neurooncol (1997) 0.99

Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys (2005) 0.97

Screening for distress in patients with brain cancer using the NCCN's rapid screening measure. Psychooncology (2008) 0.97

A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. Am J Clin Oncol (2008) 0.95

Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Arch Phys Med Rehabil (2001) 0.92

A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. BMC Cancer (2006) 0.91

Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancer. Psychooncology (2007) 0.90

Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh (2007) 0.90

Oncology staff recognition of depressive symptoms on videotaped interviews of depressed cancer patients: implications for designing a training program. J Pain Symptom Manage (2000) 0.81

Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience. Neurol Sci (2008) 0.81

Stress and intervention preferences of patients with brain tumors. Support Care Cancer (2006) 0.78

Functional outcomes and quality of life in patients with brain tumours: a review of the literature. Brain Inj (2001) 0.75

Articles by these authors

(truncated to the top 100)

Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. N Engl J Med (2015) 3.40

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood (2005) 3.26

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest (2001) 3.01

Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ (2007) 2.93

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest (2009) 2.82

Health for all beyond 2000: the demise of the Alma-Ata Declaration and primary health care in developing countries. Med J Aust (2003) 2.55

Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr (2008) 2.30

Glycemic response and health--a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr (2008) 2.14

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood (2009) 2.07

The effects of involuntary job loss on suicide and suicide attempts among young adults: evidence from a matched case-control study. Aust N Z J Psychiatry (2014) 1.98

Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol (2009) 1.84

Rapid assessment of exposure to chlorine released from a train derailment and resulting health impact. Public Health Rep (2007) 1.82

Association between Agent Orange and birth defects: systematic review and meta-analysis. Int J Epidemiol (2006) 1.82

Attributable risk of psychiatric and socio-economic factors for suicide from individual-level, population-based studies: a systematic review. Soc Sci Med (2010) 1.73

Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol (2011) 1.69

The role of under-employment and unemployment in recent birth cohort effects in Australian suicide. Soc Sci Med (2013) 1.67

Impact of misclassification on measures of cardiovascular disease mortality in the Islamic Republic of Iran: a cross-sectional study. Bull World Health Organ (2008) 1.66

Is there a dose-response relation of dietary glycemic load to risk of type 2 diabetes? Meta-analysis of prospective cohort studies. Am J Clin Nutr (2013) 1.55

The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum (2004) 1.54

Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand. Aust N Z J Public Health (2008) 1.52

Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA (2011) 1.46

More on HIV-associated Kaposi's sarcoma. N Engl J Med (2008) 1.38

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men. J Infect Dis (2010) 1.37

New information on the mechanism of forcible ascospore discharge from Ascobolus immersus. Fungal Genet Biol (2004) 1.37

Who has regular mammograms? Effects of knowledge, beliefs, socioeconomic status, and health-related factors. Prev Med (2005) 1.36

Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ J Surg (2005) 1.25

Rural Indian tribal communities: an emerging high-risk group for HIV/AIDS. BMC Int Health Hum Rights (2005) 1.24

The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): a time trend analysis. Int J Cardiol (2011) 1.23

Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial. J Urol (2008) 1.23

Mortality trends in Fiji. Aust N Z J Public Health (2011) 1.23

Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest (2011) 1.22

Mortality trends and the epidemiological transition in Nauru. Asia Pac J Public Health (2011) 1.21

Socio-economic mortality differentials in Sydney over a quarter of a century, 1970-94. Aust N Z J Public Health (2002) 1.21

High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. Magn Reson Med (2009) 1.19

Population-based mammography screening and breast cancer incidence in New South Wales, Australia. Cancer Causes Control (2006) 1.17

Cancer detection and mammogram volume of radiologists in a population-based screening programme. Breast (2005) 1.17

Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol (2002) 1.16

Intrathecal morphine for postoperative analgesia: a randomized, controlled, dose-ranging study after hip and knee arthroplasty. Anesth Analg (2003) 1.15

Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation (2002) 1.14

Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol (2007) 1.14

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. BMC Cancer (2010) 1.13

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood (2013) 1.13

Mortality and cause-of-death reporting and analysis systems in seven Pacific Island countries. BMC Public Health (2012) 1.13

Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant (2008) 1.12

Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease. J Autoimmun (1999) 1.11

Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer (2008) 1.09

Preservation of porcine non-heart-beating donor livers by sequential cold storage and warm perfusion. Transplantation (2004) 1.09

Cerebrovascular disease in 48 countries: secular trends in mortality 1950-2005. J Neurol Neurosurg Psychiatry (2011) 1.08

Causes of death in Tonga: quality of certification and implications for statistics. Popul Health Metr (2012) 1.07

Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol (2009) 1.06

Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract (2013) 1.05

Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis (2012) 1.02

Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clin Oncol (2006) 1.02

Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr (2011) 1.02

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer (2010) 1.01

Switching to fast growth: the insulin-like growth factor (IGF) system in skeletal muscle of Atlantic salmon. J Exp Biol (2008) 0.99

Paternal exposure to Agent Orange and spina bifida: a meta-analysis. Eur J Epidemiol (2009) 0.99

Quantitative immunocytochemistry using an image analyzer. I. Hardware evaluation, image processing, and data analysis. J Neurosci Methods (1988) 0.98

Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. Cancer (2011) 0.98

Further increases in rural suicide in young Australian adults: secular trends, 1979-2003. Soc Sci Med (2007) 0.98

Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr (2006) 0.96

Mortality trends in Tonga: an assessment based on a synthesis of local data. Popul Health Metr (2012) 0.96

Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol (2013) 0.95

The effects of precision, haematocrit, pH and oxygen tension on point-of-care glucose measurement in critically ill patients: a prospective study. Ann Clin Biochem (2012) 0.95

Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol (2012) 0.94

Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor. J Biol Chem (2009) 0.94

How much does a reminder letter increase cervical screening among under-screened women in NSW? Aust N Z J Public Health (2005) 0.93

Differential mortality in Iran. Popul Health Metr (2007) 0.93

Glycemic response and health--a systematic review and meta-analysis: the database, study characteristics, and macronutrient intakes. Am J Clin Nutr (2008) 0.91

Extended interval dosing of gentamicin in premature neonates ≤ 28-week gestation. Acta Paediatr (2012) 0.90

Divergent trends in suicide by socio-economic status in Australia. Soc Psychiatry Psychiatr Epidemiol (2006) 0.90

Limit-setting and decision-making in the management of aggression. J Adv Nurs (2003) 0.89

A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003. J Med Screen (2005) 0.89

Recruitment to mammography screening: a randomised trial and meta-analysis of invitation letters and telephone calls. Aust N Z J Public Health (2006) 0.89

Continued increases in hypertension over three decades in Fiji, and the influence of obesity. J Hypertens (2016) 0.88

Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trial. J Urol (2011) 0.88

Preventive evidence into practice (PEP) study: implementation of guidelines to prevent primary vascular disease in general practice protocol for a cluster randomised controlled trial. Implement Sci (2013) 0.88

Erionite in road gravel associated with interstitial and pleural changes--an occupational hazard in western United States. J Occup Environ Med (2011) 0.88

Human response to environmental noise: the role of perceived control. Int J Behav Med (2002) 0.87

Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr (2012) 0.87

Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis (2009) 0.87

A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development. Curr Top Med Chem (2007) 0.87

Divergent mortality trends by ethnicity in Fiji. Aust N Z J Public Health (2013) 0.87

Analysis of the 5' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization. Gene (2000) 0.86

New South Wales trends in mortality differentials between small rural and urban communities over a 25-year period, 1970-1994. Aust J Rural Health (2005) 0.86

Human resource challenges in scaling up the response to HIV in Papua New Guinea. Western Pac Surveill Response J (2012) 0.85

Safety and toxicity of saw palmetto in the CAMUS trial. J Urol (2012) 0.85

Global comparative assessments of life expectancy: the impact of migration with reference to Australia. Bull World Health Organ (2007) 0.85

A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS (2006) 0.85

Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism. Surgery (2010) 0.85

Knowledge, attitude and practice (KAP) concerning cervical cancer and screening among rural and urban female healthcare practitioners in the Democratic People's Republic of Korea. Asian Pac J Cancer Prev (2011) 0.85

Total anomalous pulmonary venous connection: factors associated with mortality and recurrent pulmonary venous obstruction. Ann Thorac Surg (2012) 0.84

Trends in socioeconomic inequalities in mortality from ischaemic heart disease and stroke in Australia, 1979-2006. Eur J Prev Cardiol (2011) 0.84

Mammography screening and breast cancer mortality in Australia: an aggregate cohort study. J Med Screen (2012) 0.84

Recent declines in Australian male suicide are real, not artefactual. Aust N Z J Psychiatry (2010) 0.84

Hormone replacement therapy and breast cancer risk in California. Breast J (2005) 0.84

Mental disorders and socioeconomic status: impact on population risk of attempted suicide in australia. Suicide Life Threat Behav (2009) 0.84

Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia. Cancer Causes Control (2008) 0.83

Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia. J Urol (2013) 0.83

Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization. Biotechnol Prog (2004) 0.83